Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD).

TitleHaploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD).
Publication TypeJournal Article
Year of Publication2023
AuthorsGomez-Arteaga A, Orfali N, Pasciolla M, Baptiste A, Guindine I, Hsu JM, Lin J, Mayer SA, Phillips AA, Shore TB, Simonson PD, DiCarlo E, Yoon S, Muthukumar T, Van Besien K
JournalBone Marrow Transplant
Volume58
Issue7
Pagination835-838
Date Published2023 Jul
ISSN1476-5365
KeywordsAnemia, Sickle Cell, Cyclophosphamide, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Humans, Kidney Failure, Chronic, Kidney Transplantation, Transplantation Conditioning
DOI10.1038/s41409-023-01981-x
Alternate JournalBone Marrow Transplant
PubMed ID37045941
PubMed Central ID6506220
Related Faculty: 
Paul Simonson, M.D., Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700